Shield Therapeutics plc (SHIELD THERAPEUTICS PLC ORD 1.5) aksje
STX.L
Stengt£5.85-0.05 (-0.85%)
Laster graf...
SHIELD THERAPEUTICS PLC ORD 1.5
Market Cap
$62,502,480
Åpning6.00
Høy6.00
Lav5.70
Volum798.36k
P/EN/A
Markedsverdi62.5M
52-ukers høy12.50
52-ukers lav2.30
Gj.sn. volum2.55M
UtbytteN/A
Beta1.88
EPS-0.01
Om Shield Therapeutics plc (SHIELD THERAPEUTICS PLC ORD 1.5) aksje
Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was incorporated in 2008 and is based in Gateshead, the United Kingdom.
Selskapsinformasjon
Børs: LSE (LSE)
Sektor: Sundhed
Industri: Lægemiddelproducenter – Special og generisk
Adresse:
Northern Design Centre
NE8 3DF Gateshead, United Kingdom
NE8 3DF Gateshead, United Kingdom
Telefon: + 44 1915 118 500
Nettside: https://www.shieldtherapeutics.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Laveste kursmål
14.00
↑ 139.3%
Gjennomsnittlig kursmål
17.33
↑ 196.3%
Median kursmål
15.00
↑ 156.4%
Høyeste kursmål
23.00
↑ 293.2%